Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy

<p><strong>Background:</strong><br> Left ventricular maximum wall thickness (LVMWT) is an important biomarker of left ventricular hypertrophy and provides diagnostic and prognostic information in hypertrophic cardiomyopathy (HCM). Limited information is available on the genet...

Full description

Bibliographic Details
Main Authors: Aung, N, Lopes, LR, van Duijvenboden, S, Harper, AR, Goel, A, Grace, C, Ho, CY, Weintraub, WS, Kramer, CM, Neubauer, S, Watkins, H, Petersen, SE, Munroe, PB
Format: Journal article
Language:English
Published: American Heart Association 2023
_version_ 1797109844642103296
author Aung, N
Lopes, LR
van Duijvenboden, S
Harper, AR
Goel, A
Grace, C
Ho, CY
Weintraub, WS
Kramer, CM
Neubauer, S
Watkins, H
Petersen, SE
Munroe, PB
author_facet Aung, N
Lopes, LR
van Duijvenboden, S
Harper, AR
Goel, A
Grace, C
Ho, CY
Weintraub, WS
Kramer, CM
Neubauer, S
Watkins, H
Petersen, SE
Munroe, PB
author_sort Aung, N
collection OXFORD
description <p><strong>Background:</strong><br> Left ventricular maximum wall thickness (LVMWT) is an important biomarker of left ventricular hypertrophy and provides diagnostic and prognostic information in hypertrophic cardiomyopathy (HCM). Limited information is available on the genetic determinants of LVMWT.<br><br> <strong>Methods:</strong><br> We performed a genome-wide association study of LVMWT measured from the cardiovascular magnetic resonance examinations of 42 176 European individuals. We evaluated the genetic relationship between LVMWT and HCM by performing pairwise analysis using the data from the Hypertrophic Cardiomyopathy Registry in which the controls were randomly selected from UK Biobank individuals not included in the cardiovascular magnetic resonance sub-study.<br><br> <strong>Results:</strong><br> Twenty-one genetic loci were discovered at <em>P</em><5×10<sup>−8</sup>. Several novel candidate genes were identified including <em>PROX1, PXN, and PTK2</em>, with known functional roles in myocardial growth and sarcomere organization. The LVMWT genetic risk score is predictive of HCM in the Hypertrophic Cardiomyopathy Registry (odds ratio per SD: 1.18 [95% CI, 1.13–1.23]) with pairwise analyses demonstrating a moderate genetic correlation (r<sub>g</sub>=0.53) and substantial loci overlap (19/21).<br><br> <strong>Conclusions:</strong><br> Our findings provide novel insights into the genetic underpinning of LVMWT and highlight its shared genetic background with HCM, supporting future endeavours to elucidate the genetic etiology of HCM.</p>
first_indexed 2024-03-07T07:46:59Z
format Journal article
id oxford-uuid:7470a057-73ad-4505-ab83-f7b34fe97a18
institution University of Oxford
language English
last_indexed 2024-03-07T07:46:59Z
publishDate 2023
publisher American Heart Association
record_format dspace
spelling oxford-uuid:7470a057-73ad-4505-ab83-f7b34fe97a182023-06-19T14:29:10ZGenome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7470a057-73ad-4505-ab83-f7b34fe97a18EnglishSymplectic ElementsAmerican Heart Association2023Aung, NLopes, LRvan Duijvenboden, SHarper, ARGoel, AGrace, CHo, CYWeintraub, WSKramer, CMNeubauer, SWatkins, HPetersen, SEMunroe, PB<p><strong>Background:</strong><br> Left ventricular maximum wall thickness (LVMWT) is an important biomarker of left ventricular hypertrophy and provides diagnostic and prognostic information in hypertrophic cardiomyopathy (HCM). Limited information is available on the genetic determinants of LVMWT.<br><br> <strong>Methods:</strong><br> We performed a genome-wide association study of LVMWT measured from the cardiovascular magnetic resonance examinations of 42 176 European individuals. We evaluated the genetic relationship between LVMWT and HCM by performing pairwise analysis using the data from the Hypertrophic Cardiomyopathy Registry in which the controls were randomly selected from UK Biobank individuals not included in the cardiovascular magnetic resonance sub-study.<br><br> <strong>Results:</strong><br> Twenty-one genetic loci were discovered at <em>P</em><5×10<sup>−8</sup>. Several novel candidate genes were identified including <em>PROX1, PXN, and PTK2</em>, with known functional roles in myocardial growth and sarcomere organization. The LVMWT genetic risk score is predictive of HCM in the Hypertrophic Cardiomyopathy Registry (odds ratio per SD: 1.18 [95% CI, 1.13–1.23]) with pairwise analyses demonstrating a moderate genetic correlation (r<sub>g</sub>=0.53) and substantial loci overlap (19/21).<br><br> <strong>Conclusions:</strong><br> Our findings provide novel insights into the genetic underpinning of LVMWT and highlight its shared genetic background with HCM, supporting future endeavours to elucidate the genetic etiology of HCM.</p>
spellingShingle Aung, N
Lopes, LR
van Duijvenboden, S
Harper, AR
Goel, A
Grace, C
Ho, CY
Weintraub, WS
Kramer, CM
Neubauer, S
Watkins, H
Petersen, SE
Munroe, PB
Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
title Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
title_full Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
title_fullStr Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
title_full_unstemmed Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
title_short Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
title_sort genome wide analysis of left ventricular maximum wall thickness in the uk biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
work_keys_str_mv AT aungn genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT lopeslr genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT vanduijvenbodens genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT harperar genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT goela genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT gracec genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT hocy genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT weintraubws genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT kramercm genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT neubauers genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT watkinsh genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT petersense genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy
AT munroepb genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy